Clinical Trials Logo

Clinical Trial Summary

MAGIC-MT study is multi-center, prospective, randomized (1:1) controlled trial designed to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.


Clinical Trial Description

The objective of this study is to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04700345
Study type Interventional
Source Huashan Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date March 21, 2021
Completion date June 17, 2024